We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Insulet Corporation (NASDAQ:PODD) is one of the best healthcare stocks on our list.
TheFly reported on July 6 that Evercore ISI reduced its price target on PODD to $180 from $200 while maintaining an Outperform rating on the shares. The adjustment was included in the firm’s second-quarter preview covering the MedTech, Life Sciences Tools, and Diagnostics sectors. Evercore ISI noted that industry trends remain generally positive, with healthy procedure volumes and capital expenditure activity across the sector.
On the same day, July 6, Insulet Corporation (NASDAQ:PODD) announced the commercial introduction of its Omnipod 5 Automated Insulin Delivery System along with its proprietary data management platform, Omnipod Discover, in Spain. The launch marks Spain as the company’s newest European market and expands Insulet’s global presence. Spain becomes the 26th country where PODD offers Omnipod products and the 20th market where Omnipod 5 is available. The company stated that the expansion supports its broader goal of improving diabetes management and helping more people worldwide benefit from its automated insulin delivery technology.
Insulet Corporation (NASDAQ:PODD) is a global diabetes care innovator best known for its Omnipod tubeless insulin delivery platform. Its flagship Omnipod 5 Automated Insulin Delivery System integrates with continuous glucose monitors (CGMs) to automatically adjust insulin levels, offering a wearable, smartphone-controlled alternative to daily injections.
While we acknowledge the potential of PODD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
